Evidence map›Paper›PMID 36092947›Full record

ArticleTransport policy2022

Ghostbusters: Hunting abnormal flights in Europe during COVID-19.

Xiaoqian Sun, Sebastian Wandelt, Anming Zhang

Abstract read
In one paragraph

Article in Transport policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoqian SunNational Key Laboratory of CNS/ATM, School of Electronic and Information Engineering, Beihang University, 100191 Beijing, China.
Sebastian WandeltNational Key Laboratory of CNS/ATM, School of Electronic and Information Engineering, Beihang University, 100191 Beijing, China.
Anming ZhangSauder School of Business, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of the COVID-19 pandemic is unprecedented in airline history, with irregular flight bans, the inability for accurate demand estimation, several turns in the epidemiological evolution, and a wide range of downstream effects on all aviation stakeholders. While most airlines have increasingly entered a recovery stage, compared to the utmost disruption around April 2020, the airline business is far from back-to-normality. Throughout the past two years, recurrent statements have been made regarding the existence of so-called ghost flights, where airlines operate nearly empty aircraft on markets with insufficient demand, partially with the aim to avoid losing precious airport slots. This study investigates the extent of such abnormal market service during the COVID-19 pandemic through an explorative, data-driven analysis, based on actual load factor data of European airlines for the years 2017 to 2021. We break down the observed deviations by airlines, markets, and airports. We find that low-cost carriers are most-likely to have performed abnormal flights during the pandemic; and that abnormal flights have mostly occurred on frequently-served markets. In addition, we show that airline responses, in terms of departure and yield changes, are largely heterogeneous across the 24 airlines in this study. Our study is the first one to shed light on the important issue of load factor deviations, and we hope that our findings can contribute to a better understanding of the existence of abnormal flights during the pandemic, as well as deriving appropriate policies for dealing with the ubiquitous threat and impact of ghost flights in the future.

Indexed as

COVID-19EuropeGhost flightsLoad factorPandemic

Identifiers

PMID36092947
PMCPMC9444478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.